A new diagnostic testing reagent for the novel coronavirus developed by Kyorin Pharmaceutical Co. will be released in mid-April, parent company Kyorin Holdings Inc. said Tuesday.
The reagent makes it possible to test patients for the virus in about 15 minutes when used together with a genetic testing device jointly developed by the group and the industry ministry-affiliated National Institute of Advanced Industrial Science and Technology, known as AIST.
The current common COVID-19 testing method in Japan takes four to six hours to obtain results.
The testing device has been introduced at 16 medical institutions around Japan.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
Your news needs your support
Since the early stages of the COVID-19 crisis, The Japan Times has been providing free access to crucial news on the impact of the novel coronavirus as well as practical information about how to cope with the pandemic. Please consider subscribing today so we can continue offering you up-to-date, in-depth news about Japan.